(PEGA) Pegasystems - Overview
Sector: TechnologyIndustry: Software - Application | Exchange NASDAQ (USA) | Currency USD | Market Cap: 7.529m | Total Return 11.3% in 12m
Stock: Software, Automation, AI, Platform
| Risk 5d forecast | |
|---|---|
| Volatility | 55.5% |
| Relative Tail Risk | -13.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.38 |
| Alpha | -6.94 |
| Character TTM | |
|---|---|
| Beta | 1.398 |
| Beta Downside | 1.290 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.38% |
| CAGR/Max DD | 0.52 |
EPS (Earnings per Share)
Revenue
Risks
Description: PEGA Pegasystems March 04, 2026
Pegasystems Inc. (PEGA) develops and markets enterprise software globally. Its offerings include Pega Infinity, a suite of applications for customer engagement and workflow automation.
The companys Pega Customer Decision Hub uses AI to predict customer behavior and recommend actions, a key component in the customer relationship management (CRM) software sector. Pega Customer Service focuses on enhancing customer interactions and employee productivity. Pega Platform provides AI-powered workflow automation, addressing a growing demand for operational efficiency in enterprise software.
PEGA also offers development tools like Pega GenAI Blueprint for rapid prototyping and cloud services through Pega Cloud. The company provides training via Pega Academy and global support. PEGA primarily targets large enterprises in sectors such as financial services, healthcare, and government, a common business model for enterprise software providers.
Further research into PEGAs financial performance and market position can be found on ValueRay.
Headlines to watch out for
- Subscription revenue growth from Pega Infinity drives stock performance
- Cloud adoption rates impact recurring revenue streams
- AI-powered workflow automation demand boosts license sales
- Competition in enterprise software market pressures pricing
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income: 393.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.30 > 0.02 and ΔFCF/TA 10.94 > 1.0 |
| NWC/Revenue: 13.78% < 20% (prev 16.54%; Δ -2.76% < -1%) |
| CFO/TA 0.31 > 3% & CFO 505.2m > Net Income 393.4m |
| Net Debt (-136.5m) to EBITDA (307.8m): -0.44 < 3 |
| Current Ratio: 1.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (184.2m) vs 12m ago -3.72% < -2% |
| Gross Margin: 75.86% > 18% (prev 0.74%; Δ 7.51k% > 0.5%) |
| Asset Turnover: 102.7% > 50% (prev 84.67%; Δ 18.02% > 0%) |
| Interest Coverage Ratio: 219.4 > 6 (EBITDA TTM 307.8m / Interest Expense TTM 1.28m) |
Altman Z'' 3.57
| A: 0.15 (Total Current Assets 978.3m - Total Current Liabilities 737.8m) / Total Assets 1.63b |
| B: 0.28 (Retained Earnings 463.4m / Total Assets 1.63b) |
| C: 0.17 (EBIT TTM 281.9m / Avg Total Assets 1.70b) |
| D: 0.54 (Book Value of Equity 456.5m / Total Liabilities 844.5m) |
| Altman-Z'' Score: 3.57 = A |
Beneish M -2.74
| DSRI: 0.75 (Receivables 482.6m/552.9m, Revenue 1.75b/1.50b) |
| GMI: 0.97 (GM 75.86% / 73.91%) |
| AQI: 1.80 (AQ_t 0.34 / AQ_t-1 0.19) |
| SGI: 1.17 (Revenue 1.75b / 1.50b) |
| TATA: -0.07 (NI 393.4m - CFO 505.2m) / TA 1.63b) |
| Beneish M-Score: -2.74 (Cap -4..+1) = A |
What is the price of PEGA shares?
Over the past week, the price has changed by -1.25%, over one month by -3.07%, over three months by -32.45% and over the past year by +11.25%.
Is PEGA a buy, sell or hold?
- StrongBuy: 7
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PEGA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 59.8 | 42.6% |
| Analysts Target Price | 59.8 | 42.6% |
PEGA Fundamental Data Overview March 25, 2026
P/E Forward = 15.8228
P/S = 4.3126
P/B = 9.3219
P/EG = 15.2095
Revenue TTM = 1.75b USD
EBIT TTM = 281.9m USD
EBITDA TTM = 307.8m USD
Long Term Debt = 76.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 15.1m USD (from shortTermDebt, last quarter)
Debt = 76.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -136.5m USD (from netDebt column, last quarter)
Enterprise Value = 7.18b USD (7.53b + Debt 76.0m - CCE 425.8m)
Interest Coverage Ratio = 219.4 (Ebit TTM 281.9m / Interest Expense TTM 1.28m)
EV/FCF = 14.63x (Enterprise Value 7.18b / FCF TTM 490.7m)
FCF Yield = 6.84% (FCF TTM 490.7m / Enterprise Value 7.18b)
FCF Margin = 28.11% (FCF TTM 490.7m / Revenue TTM 1.75b)
Net Margin = 22.54% (Net Income TTM 393.4m / Revenue TTM 1.75b)
Gross Margin = 75.86% ((Revenue TTM 1.75b - Cost of Revenue TTM 421.4m) / Revenue TTM)
Gross Margin QoQ = 79.48% (prev 72.23%)
Tobins Q-Ratio = 4.40 (Enterprise Value 7.18b / Total Assets 1.63b)
Interest Expense / Debt = 0.15% (Interest Expense 113k / Debt 76.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = 222.7m (EBIT 281.9m * (1 - 21.00%))
Current Ratio = 1.33 (Total Current Assets 978.3m / Total Current Liabilities 737.8m)
Debt / Equity = 0.10 (Debt 76.0m / totalStockholderEquity, last quarter 787.4m)
Debt / EBITDA = -0.44 (Net Debt -136.5m / EBITDA 307.8m)
Debt / FCF = -0.28 (Net Debt -136.5m / FCF TTM 490.7m)
Total Stockholder Equity = 655.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 23.14% (Net Income 393.4m / Total Assets 1.63b)
RoE = 60.07% (Net Income TTM 393.4m / Total Stockholder Equity 655.0m)
RoCE = 38.57% (EBIT 281.9m / Capital Employed (Equity 655.0m + L.T.Debt 76.0m))
RoIC = 34.00% (NOPAT 222.7m / Invested Capital 655.0m)
WACC = 10.79% (E(7.53b)/V(7.60b) * Re(10.90%) + D(76.0m)/V(7.60b) * Rd(0.15%) * (1-Tc(0.21)))
Discount Rate = 10.90% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.46%
[DCF] Terminal Value 73.03% ; FCFF base≈429.7m ; Y1≈530.1m ; Y5≈904.5m
[DCF] Fair Price = 58.82 (EV 9.81b - Net Debt -136.5m = Equity 9.94b / Shares 169.0m; r=10.79% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 42.05 | EPS CAGR: 6.99% | SUE: 0.06 | # QB: 0
Revenue Correlation: 60.56 | Revenue CAGR: 8.12% | SUE: 0.27 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.47 | Chg7d=+0.000 | Chg30d=+0.107 | Revisions Net=+6 | Analysts=9
EPS current Year (2026-12-31): EPS=2.71 | Chg7d=+0.002 | Chg30d=+0.485 | Revisions Net=-1 | Growth EPS=+29.0% | Growth Revenue=+13.7%
EPS next Year (2027-12-31): EPS=3.03 | Chg7d=-0.007 | Chg30d=+0.492 | Revisions Net=+1 | Growth EPS=+11.9% | Growth Revenue=+11.5%
[Analyst] Revisions Ratio: +0.60 (8 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 10.9% - Earnings Yield 4.8%)
[Growth] Growth Spread = +7.8% (Analyst 13.9% - Implied 6.1%)